|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LIVER DISEASE |
1 Dip Medicina e Oncologia Sperimentale, University of Torino, Italy
2 Dip Medicina Interna-Centro di Ricerca, Trasferimento e Alta Formazione "DENOTHE", University of Florence, Italy
Correspondence to:
Correspondence to:
Professor M Parola
Università degli Studi di Torino, Dip Medicina e Oncologia Sperimentale, C so Raffaello 30, 10125 Torino, Italy; maurizio.parola{at}unito.it
Background and aims: Myofibroblast-like cells, originating from activation of hepatic stellate cells (HSC/MFs), play a key role in liver fibrosis, a potentially reversible process that may rely on induction of HSC/MFs apoptosis. While this possibility has been shown in cultured rat HSC, very limited data are currently available for human HSC/MFs.
Methods: Cultured human HSC/MFs were exposed to several proapoptotic stimuli, including those known to induce apoptosis in rat HSC/MFs, and induction of cell death and related mechanisms were investigated using morphology, molecular biology, and biochemical techniques.
Results: In this study we report that fully activated human HSC/MFs did not undergo spontaneous apoptosis and survived to prolonged serum deprivation, Fas activation, or exposure to nerve growth factor, tumour necrosis factor
(TNF-
), oxidative stress mediators, doxorubicin, and etoposide. Induction of caspase dependent, mitochondria driven apoptosis in HSC/MFs was observed only when protein synthesis or transcription were inhibited. Importantly, the process of HSC activation was accompanied by changes in expression of a set of genes involved in apoptosis control. In particular, activated human HSC/MFs in culture overexpressed Bcl-2. The role of Bcl-2 was crucial as Bcl-2 silenced cells became susceptible to TNF-
induced apoptosis. Finally, Bcl-2 was markedly expressed in HSC/MFs present in liver tissue obtained from patients with hepatitis C virus related cirrhosis.
Conclusions: Human activated HSC/MFs are resistant to most proapoptotic stimuli due to Bcl-2 overexpression and this feature may play a key role in the progression of fibrosis in chronic liver diseases.
Abbreviations: CLDs, chronic liver diseases; DAPI, 4,6-diamidine-2-phenylindole di-hydrochloride; 
m, mitochondrial membrane potential; ECL, enhanced chemiluminescence; ERK, extracellular regulated kinase; FasL, Fas ligand; HCV, hepatitis C virus; HSC, hepatic stellate cells; HSC/MFs, activated hepatic stellate cells in myofibroblast-like phenotype; JC-1, J-aggregate forming lipophilic cation; LDH, lactate dehydrogenase; mAb, monoclonal antibody; NGF, nerve growth factor; NF
B, nuclear factor
B; PARP, poly (ADP ribose) polymerase; SFI medium, serum free Iscoves medium;
-SMA,
smooth muscle actin; siRNA, small interfering RNA; TBS, Tris buffered saline; h-TERT, human telomerase catalytic subunit; TIMP, tissue inhibitor of metalloproteinases; TNF-
, tumour necrosis factor
; TrkA, tyrosine kinase A
Keywords: activated human hepatic stellate cells; liver fibrosis; apoptosis; Bcl-2; induction of cell death
Relevant Article
Gut 2006 55: 1073-1074.
This article has been cited by other articles:
![]() |
E. Novo, S. Cannito, E. Zamara, L. V. di Bonzo, A. Caligiuri, C. Cravanzola, A. Compagnone, S. Colombatto, F. Marra, M. Pinzani, et al. Proangiogenic Cytokines as Hypoxia-Dependent Factors Stimulating Migration of Human Hepatic Stellate Cells Am. J. Pathol., June 1, 2007; 170(6): 1942 - 1953. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Passino, R. A. Adams, S. L. Sikorski, and K. Akassoglou Regulation of Hepatic Stellate Cell Differentiation by the Neurotrophin Receptor p75NTR Science, March 30, 2007; 315(5820): 1853 - 1856. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Kawada Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease. Gut, August 1, 2006; 55(8): 1073 - 1074. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |